These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16456095)

  • 21. Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk.
    Eisenhardt SU; Habersberger J; Peter K
    Trends Cardiovasc Med; 2009 Oct; 19(7):232-7. PubMed ID: 20382347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
    J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4.
    Hebecker M; Okemefuna AI; Perkins SJ; Mihlan M; Huber-Lang M; Józsi M
    Mol Immunol; 2010 Mar; 47(6):1347-55. PubMed ID: 20042240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
    Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
    Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
    Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
    Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue.
    Mitchell DA; Kirby L; Paulin SM; Villiers CL; Sim RB
    Mol Immunol; 2007 Apr; 44(11):2997-3004. PubMed ID: 17337056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
    Yang XW; Tan Y; Yu F; Zhao MH
    Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q.
    Roumenina LT; Kantardjiev AA; Atanasov BP; Waters P; Gadjeva M; Reid KB; Mantovani A; Kishore U; Kojouharova MS
    Biochemistry; 2005 Nov; 44(43):14097-109. PubMed ID: 16245926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conduct unbecoming: C-reactive protein interactions with a broad range of protein molecules.
    Boguslawski G; McGlynn PW; Potempa LA; Filep JG; Labarrere CA
    J Heart Lung Transplant; 2007 Jul; 26(7):705-13. PubMed ID: 17613401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
    Berman S; Gewurz H; Mold C
    J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of model soluble immune complexes to modified C-reactive protein.
    Motie M; Brockmeier S; Potempa LA
    J Immunol; 1996 Jun; 156(11):4435-41. PubMed ID: 8666818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonimmune activation of the classical complement pathway.
    Gewurz H; Ying SC; Jiang H; Lint TF
    Behring Inst Mitt; 1993 Dec; (93):138-47. PubMed ID: 8172561
    [No Abstract]   [Full Text] [Related]  

  • 34. [Is C-reactive protein a marker of inflammation?].
    Dupuy AM; Terrier N; Sénécal L; Morena M; Leray H; Canaud B; Cristol JP
    Nephrologie; 2003; 24(7):337-41. PubMed ID: 14650743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation.
    van der Zee PM; Biró E; Trouw LA; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Immunol; 2010 Jun; 135(3):490-5. PubMed ID: 20138585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein.
    van Tits L; de Graaf J; Toenhake H; van Heerde W; Stalenhoef A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):717-22. PubMed ID: 15692104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).
    Ji SR; Wu Y; Zhu L; Potempa LA; Sheng FL; Lu W; Zhao J
    FASEB J; 2007 Jan; 21(1):284-94. PubMed ID: 17116742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
    Jiang H; Robey FA; Gewurz H
    J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement protein C1q recognizes enzymatically modified low-density lipoprotein through unesterified fatty acids generated by cholesterol esterase.
    Biro A; Ling WL; Arlaud GJ
    Biochemistry; 2010 Mar; 49(10):2167-76. PubMed ID: 20166680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemonchus contortus calreticulin binds to C-reactive protein of its host, a novel survival strategy of the parasite.
    Suchitra S; Anbu KA; Rathore DK; Mahawar M; Singh BP; Joshi P
    Parasite Immunol; 2008; 30(6-7):371-4. PubMed ID: 18422872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.